This inventor holds 1 USPTO granted patent. Top assignee: The General Hospital Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Kenton J Swartz: Innovator in Neurological Disease Treatment
Introduction
Kenton J Swartz is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of neurological diseases. His innovative approach focuses on increasing brain concentrations of kynurenic acid to alleviate conditions such as Huntington's disease.
Latest Patents
Kenton J Swartz holds 1 patent for his work titled "Treatment of neurological diseases by increasing brain concentrations of kynurenic acid." This patent addresses the toxic effects of excitatory amino acids in neurological diseases. By administering metabolic precursors of kynurenic acid, such as kynurenine and tryptophan, he aims to improve the conditions of afflicted individuals. His research highlights that patients with Huntington's disease have lower levels of kynurenic acid in their brains, which correlates with the formation of lesions associated with the disease.
Career Highlights
Kenton J Swartz is affiliated with The General Hospital Corporation, where he continues to advance his research in neurological treatments. His work has garnered attention for its potential to change the landscape of how neurological diseases are treated.
Collaborations
Some of his notable coworkers include M Flint Beal and Andrew Freese, who have contributed to the research and development of his innovative ideas.
Conclusion
Kenton J Swartz's contributions to the treatment of neurological diseases through his patent on kynurenic acid represent a significant advancement in medical science. His work continues to inspire further research and innovation in the field.